In both age subgroups, there was a positive trend consistently favoring the OAV101 IT group compared with sham.
← all excerpts
Intrathecal onasemnogene abeparvovec in treatment-naive patients with spinal muscular atrophy: a phase 3, randomized controlled trial.
1
—
—